Janumet xr and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Janumet xr (metformin hydrochloride; sitagliptin phosphate), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Zofran, and have Nausea.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Janumet xr. It is created by eHealthMe based on reports of 2,311 people who have side effects when taking Janumet xr from the FDA, and is updated regularly.

What is Janumet xr?

Janumet xr has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is often used in type 2 diabetes. eHealthMe is studying from 2,357 Janumet xr users. Check the latest studies of Janumet xr.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,013 drugs and 3,957 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Jul, 10, 2026

2,311 people reported to have side effects when taking Janumet xr.
Among them, 24 people (1.04%) have Urinary tract infection.

Could Janumet xr cause Urinary tract infection?

Among these 24 people:

How long have people been on Janumet xr when they have Urinary tract infection? *

What is the gender of people who have Urinary tract infection when taking Janumet xr? *

female: 60.87 %
male: 39.13 %

What is the age of people who have Urinary tract infection when taking Janumet xr? *

What are other drugs people take besides Janumet xr? *

What are other side effects people have besides Urinary tract infection? *

Diarrhea: 6 people, 25.00%
Dizziness: 5 people, 20.83%
Urination - Painful: 4 people, 16.67%
Stress And Anxiety: 4 people, 16.67%
White Blood Cell Count Decreased: 3 people, 12.50%
Pain: 3 people, 12.50%
Anorectal Infection: 3 people, 12.50%
Blindness: 3 people, 12.50%
Blood Glucose Increased: 3 people, 12.50%
Chest Pain: 3 people, 12.50%

What are the existing conditions these people have? *

B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 3 people, 12.50%
Nausea (feeling of having an urge to vomit): 3 people, 12.50%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 8.33%
Pain: 2 people, 8.33%
High Blood Cholesterol: 2 people, 8.33%
Multiple Myeloma (cancer of the plasma cells): 2 people, 8.33%
Insomnia (sleeplessness): 1 person, 4.17%
Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 1 person, 4.17%
Depression: 1 person, 4.17%
High Blood Pressure: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Janumet xr and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Janumet xr:

Janumet xr (2,357 reports)

Urinary tract infection treatments and more:

Urinary tract infection (281,658 reports)

How severe was Urinary tract infection and when was it recovered:

Urinary tract infection in Janumet xr

Expand to all the drugs that have ingredients of metformin hydrochloride; sitagliptin phosphate:

Urinary tract infection and drugs with ingredients of metformin hydrochloride; sitagliptin phosphate (211 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Janumet xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,013 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride; sitagliptin phosphate (the active ingredients of Janumet xr) and Janumet xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.